PLATINUM LONG TERM GROWTH VII SC 13G 5-11-2011

Company

Vistagen Therapeutics, Inc.

Filed

August 1, 2011

Accession Number

0001140361-11-038701

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →